Clinical evaluation of sulbactam/cefoperazone (SBT/CPZ Sulperazon) in oromaxillofacial infection and phleqmon in the fields of oral surgery.

DOI 1 Citations
  • SASAKI JIRO
    Department of Oral Surgery, School of Medicine, Tokai University
  • KANEKO AKIHIRO
    Department of Oral Surgery, School of Medicine, Tokai University
  • MORIHANA TAKEFUMI
    Department of Oral Surgery, School of Medicine, Tokai University
  • TOMITA FUMISADA
    Department of Oral Surgery, School of Medicine, Tokai University
  • SHIKI KAZUO
    Department of Dentistry and Oral Surgery, Iwaki Kyoritu General Hospital
  • YAMANE NOBUO
    Department of Dentistry and Oral Surgery, Iwaki Kyoritu General Hospital
  • SAKAMOTO HARUO
    Department of Dentistry and Oral Surgery, Ashikaga Sekijuji Hospital

Bibliographic Information

Other Title
  • 口腔外科領域の顎炎・蜂巣炎に対するＳｕｌｐｅｒａｚｏｎ（ＳＢＴ／ＣＰＺ）の臨床使用成績

Search this article

Description

Clincal evaluation of sulbactam/cefoperazone was carried out in 10 cases of osteitis of jaw and in 8cases of cellulitis.<BR>1. The clinical efficacy rate was 77.8 % according to the evaluation score on the 3rd day of treatment, and 72.2 % by the doctor's judgement.<BR>2. Of 14 patients who failed to respond to previous antibiotic treatments, 11 (78.6 %) were effectively treated by SBT/CPZ.<BR>3. MICs of SBT/CPZ against aerobic and anaerobic bacteria were low, and SBT/CPZ resistant strains were not found.<BR>4. As for side effects, they were moderate-some diarrhea appeared in one case. Abnormal findings in the hepatic function test were noted in 3 cases, but the changes were not clinically important.<BR>5. These results indicate the usefulness of sulbactam/cefoperazone in the treatment of odontogenic infections.

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

  • CRID
    1390282679705588608
  • NII Article ID
    130004040337
  • DOI
    10.11263/jsotp1982.10.200
  • ISSN
    18844928
    02881012
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
    • Crossref
  • Abstract License Flag
    Disallowed

Report a problem

Back to top